Lab21
About Lab21
Lab21 is a rapidly growing healthcare diagnostics business. The company’s vision is of providing personalised diagnostic testing for disease identification, disease predisposition and personalised medicine to protect people from the health problems of tomorrow. We believe that ‘prevention is better than cure’ and aim to provide information that helps to protect people from their health problems of tomorrow.Lab 21 Clinical Laboratory supports healthcare providers and the pharmaceutical and biotechnology industries with technically advanced testing services from its accredited facilities in Cambridge, UK. The Lab 21 team’s experience and know-how is coupled with a rapidly growing portfolio of molecular and viral diagnostics, plus next generation sequencing, pharmacogenetic and patient profiling tests, which all use cutting-edge technology. This unique combination adds value to pharmaceutical, diagnostic and biotech partners – and directly to clinicians or healthcare providers as they treat and monitor their patients.As we move towards truly personalised healthcare, the Lab 21 team contributes today – delivering high-quality information on drugs and patients that provides real clinical insight.
Company Metrics
- Employees: 51-100
- Monthly Visits: None
- Tech Stack: None active products
Financial Information
- Estimated Revenue:
- Total Funding: 13837128 USD
- Last Funding: 5000000 GBP (Venture - Series Unknown)
- Funding Status: M&A
Technology Stack
Lab21 actively uses None products in their tech stack.
Market Presence
Industries: Biotechnology, Health Care, Health Diagnostics, Information Technology
Headquarters: Cambridge, Cambridgeshire, United Kingdom